Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: A role for MARCKS in acquired resistance to proteasome inhibitors

10.18632/oncotarget.11340

Saved in:

Bibliographic Details
Main Authors:	Franke, N.E, Kaspers, G.L, Assaraf, Y.G, Meerloo, J, Niewerth, D, Kessler, F.L, Poddighe, P.J, Kole, J, Smeets, S.J, Ylstra, B, Bi, C, Chng, W.J, Horton, T.M, Menezes, R.X, Musters, R.J.P, Zweegman, S, Jansen, G, Cloos, J
Other Authors:	MEDICINE
Format:	Article
Published:	2020
Subjects:	asparaginase macrogol bortezomib cyclophosphamide DNA doxorubicin etoposide MARCKS protein messenger RNA methotrexate microRNA prednisone ubiquitin vincristine antineoplastic agent proteasome inhibitor acute lymphoblastic leukemia Article cancer prognosis CCRF CEM cell line controlled study down regulation exocytosis gene expression profiling gene expression regulation human human cell in vitro study leukemia cell MARCKS gene microarray analysis oncogene protein degradation protein expression upregulation comparative genomic hybridization drug resistance gene regulatory network genetics leukemia metabolism mortality prognosis tumor cell line ubiquitination Antineoplastic Agents Bortezomib Cell Line, Tumor Comparative Genomic Hybridization Drug Resistance, Neoplasm Exocytosis Gene Expression Profiling Gene Expression Regulation, Leukemic Gene Regulatory Networks Humans Leukemia MicroRNAs Myristoylated Alanine-Rich C Kinase Substrate Prognosis Proteasome Inhibitors Ubiquitin Ubiquitination Up-Regulation
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/174104
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-174104
record_format	dspace
spelling	sg-nus-scholar.10635-1741042024-04-24T05:54:25Z Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: A role for MARCKS in acquired resistance to proteasome inhibitors Franke, N.E Kaspers, G.L Assaraf, Y.G Meerloo, J Niewerth, D Kessler, F.L Poddighe, P.J Kole, J Smeets, S.J Ylstra, B Bi, C Chng, W.J Horton, T.M Menezes, R.X Musters, R.J.P Zweegman, S Jansen, G Cloos, J MEDICINE asparaginase macrogol bortezomib cyclophosphamide DNA doxorubicin etoposide MARCKS protein messenger RNA methotrexate microRNA prednisone ubiquitin vincristine antineoplastic agent bortezomib MARCKS protein microRNA proteasome inhibitor ubiquitin acute lymphoblastic leukemia Article cancer prognosis CCRF CEM cell line controlled study down regulation exocytosis gene expression profiling gene expression regulation human human cell in vitro study leukemia cell MARCKS gene microarray analysis oncogene protein degradation protein expression upregulation comparative genomic hybridization drug resistance gene regulatory network genetics leukemia metabolism mortality prognosis tumor cell line ubiquitination Antineoplastic Agents Bortezomib Cell Line, Tumor Comparative Genomic Hybridization Drug Resistance, Neoplasm Exocytosis Gene Expression Profiling Gene Expression Regulation, Leukemic Gene Regulatory Networks Humans Leukemia MicroRNAs Myristoylated Alanine-Rich C Kinase Substrate Prognosis Proteasome Inhibitors Ubiquitin Ubiquitination Up-Regulation 10.18632/oncotarget.11340 Oncotarget 7 46 74779-74796 2020-09-03T10:30:37Z 2020-09-03T10:30:37Z 2016 Article Franke, N.E, Kaspers, G.L, Assaraf, Y.G, Meerloo, J, Niewerth, D, Kessler, F.L, Poddighe, P.J, Kole, J, Smeets, S.J, Ylstra, B, Bi, C, Chng, W.J, Horton, T.M, Menezes, R.X, Musters, R.J.P, Zweegman, S, Jansen, G, Cloos, J (2016). Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: A role for MARCKS in acquired resistance to proteasome inhibitors. Oncotarget 7 (46) : 74779-74796. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.11340 19492553 https://scholarbank.nus.edu.sg/handle/10635/174104 Unpaywall 20200831
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	asparaginase macrogol bortezomib cyclophosphamide DNA doxorubicin etoposide MARCKS protein messenger RNA methotrexate microRNA prednisone ubiquitin vincristine antineoplastic agent bortezomib MARCKS protein microRNA proteasome inhibitor ubiquitin acute lymphoblastic leukemia Article cancer prognosis CCRF CEM cell line controlled study down regulation exocytosis gene expression profiling gene expression regulation human human cell in vitro study leukemia cell MARCKS gene microarray analysis oncogene protein degradation protein expression upregulation comparative genomic hybridization drug resistance gene regulatory network genetics leukemia metabolism mortality prognosis tumor cell line ubiquitination Antineoplastic Agents Bortezomib Cell Line, Tumor Comparative Genomic Hybridization Drug Resistance, Neoplasm Exocytosis Gene Expression Profiling Gene Expression Regulation, Leukemic Gene Regulatory Networks Humans Leukemia MicroRNAs Myristoylated Alanine-Rich C Kinase Substrate Prognosis Proteasome Inhibitors Ubiquitin Ubiquitination Up-Regulation
spellingShingle	asparaginase macrogol bortezomib cyclophosphamide DNA doxorubicin etoposide MARCKS protein messenger RNA methotrexate microRNA prednisone ubiquitin vincristine antineoplastic agent bortezomib MARCKS protein microRNA proteasome inhibitor ubiquitin acute lymphoblastic leukemia Article cancer prognosis CCRF CEM cell line controlled study down regulation exocytosis gene expression profiling gene expression regulation human human cell in vitro study leukemia cell MARCKS gene microarray analysis oncogene protein degradation protein expression upregulation comparative genomic hybridization drug resistance gene regulatory network genetics leukemia metabolism mortality prognosis tumor cell line ubiquitination Antineoplastic Agents Bortezomib Cell Line, Tumor Comparative Genomic Hybridization Drug Resistance, Neoplasm Exocytosis Gene Expression Profiling Gene Expression Regulation, Leukemic Gene Regulatory Networks Humans Leukemia MicroRNAs Myristoylated Alanine-Rich C Kinase Substrate Prognosis Proteasome Inhibitors Ubiquitin Ubiquitination Up-Regulation Franke, N.E Kaspers, G.L Assaraf, Y.G Meerloo, J Niewerth, D Kessler, F.L Poddighe, P.J Kole, J Smeets, S.J Ylstra, B Bi, C Chng, W.J Horton, T.M Menezes, R.X Musters, R.J.P Zweegman, S Jansen, G Cloos, J Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: A role for MARCKS in acquired resistance to proteasome inhibitors
description	10.18632/oncotarget.11340
author2	MEDICINE
author_facet	MEDICINE Franke, N.E Kaspers, G.L Assaraf, Y.G Meerloo, J Niewerth, D Kessler, F.L Poddighe, P.J Kole, J Smeets, S.J Ylstra, B Bi, C Chng, W.J Horton, T.M Menezes, R.X Musters, R.J.P Zweegman, S Jansen, G Cloos, J
format	Article
author	Franke, N.E Kaspers, G.L Assaraf, Y.G Meerloo, J Niewerth, D Kessler, F.L Poddighe, P.J Kole, J Smeets, S.J Ylstra, B Bi, C Chng, W.J Horton, T.M Menezes, R.X Musters, R.J.P Zweegman, S Jansen, G Cloos, J
author_sort	Franke, N.E
title	Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: A role for MARCKS in acquired resistance to proteasome inhibitors
title_short	Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: A role for MARCKS in acquired resistance to proteasome inhibitors
title_full	Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: A role for MARCKS in acquired resistance to proteasome inhibitors
title_fullStr	Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: A role for MARCKS in acquired resistance to proteasome inhibitors
title_full_unstemmed	Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: A role for MARCKS in acquired resistance to proteasome inhibitors
title_sort	exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for marcks in acquired resistance to proteasome inhibitors
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/174104
_version_	1800914212935958528

Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: A role for MARCKS in acquired resistance to proteasome inhibitors

Similar Items